A survey of patient and physician acceptance of skin toxicities from anti-epidermal growth factor receptor therapies
Crossref DOI link: https://doi.org/10.1007/s00520-017-3938-7
Published Online: 2017-11-07
Published Print: 2018-04
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Tischer, Bernd
Bilang, Martina
Kraemer, Matthias
Ronga, Philippe
Lacouture, Mario E.
Funding for this research was provided by:
Merck KGaA, Darmstadt, Germany
NIH/NCI Cancer Center Support Grant (P30 CA008748)
License valid from 2017-11-07